Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect

• Published in: Neuroscience research Vol. 55; no. 2; pp. 197 - 203
• Main Authors: Kwon, Young Bae, Yoon, Seo Yeon, Kim, Hyun Woo, Roh, Dae Hyun, Kang, Seuk Yun, Ryu, Yeon Hee, Choi, Sun Mi, Han, Ho Jae, Lee, Hye Jung, Kim, Kee Won, Beitz, Alvin J., Lee, Jang Hern
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 01.06.2006
• Subjects: Adrenergic Agents - pharmacology; Animals; Anti-Inflammatory Agents - therapeutic use; Bee venom; Bee Venoms - therapeutic use; Capsaicin - pharmacology; Capsaicin-sensitive primary afferent fibers; Disease Models, Animal; Diterpenes - pharmacology; Drug Interactions; Fos; Functional Laterality; Gene Expression - drug effects; Inflammation; Inflammation - chemically induced; Inflammation - drug therapy; Leukocytes - drug effects; Leukocytes - physiology; Locus coeruleus; Locus Coeruleus - drug effects; Locus Coeruleus - metabolism; Mice; Mice, Inbred ICR; Norepinephrine - metabolism; Oncogene Proteins v-fos - metabolism; Oxidopamine - pharmacology; Sciatic Neuropathy - diet therapy; Sciatic Neuropathy - pathology; Sciatic Neuropathy - physiopathology; Zymosan; Inflammation; Capsaicin-sensitive primary afferent fibers; Fos; Bee venom; Locus coeruleus
• ISSN: 0168-0102; 1872-8111
• DOI: 10.1016/j.neures.2006.03.003

Several lines of evidence indicate significant interactions between the immune and nervous systems. Our recent study reveals that ‘bee venom (BV) induced anti-inflammatory effect’ (BVAI) was produced by sympathetic preganglionic neuronal activation and subsequent adrenomedullary catecholamine release in a zymosan-induced inflammation model. However, the specific peripheral input and the supraspinal neuronal systems that are involved in this BVAI remain to be defined. Here we show that subcutaneous BV injection into left hind limb significantly reduces zymosan-induced leukocyte migration and that this effect is completely inhibited by denervation of the left sciatic nerve. This BVAI was not affected by the destruction of capsaicin-sensitive primary afferent fibers using either neonatal capsaicin or resiniferatoxin (RTX) pretreatment. BV injection into the left hind limb significantly increased Fos expression in the contralateral locus coeruleus (LC) in non-inflamed mice. In zymosan-inflamed mice, BV injection produced a further increase in LC Fos expression as compared with non-inflamed mice. This BV-induced Fos increase in the LC was not affected by RTX pretreatment. Pharmacological blockage of central noradrenergic activity by either central chemical sympathectomy (i.c.v. 6-hydroxydopamine) or alpha2 adrenoceptor antagonism (i.c.v. idazoxan) completely blocked BVAI. Taken together, these results suggest that BVAI is mediated by peripheral activation of capsaicin-insensitive primary afferent fibers and subsequent central noradrenergic activation including the LC.